Post hoc analysis of SPRINT: in 2736 propensity-matched participants, single-pill combinations vs equivalent multi-pill therapy was associated with higher odds of target BP by 6 months (OR 1.22, 95% CI 1.05-1.42); CV events and serious adverse events did not differ significantly.
Secondary analysisn = 2,736
Rao et al. Association between single-pill combination therapy use and blood pressure control in the Systolic Blood Pressure Reduction Intervention Trial: a post hoc analysis